A new antihistaminic drug (Tavegyl) in allergic diseases.
D002974:Clemastine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008297:Male; D011759:Pyrrolidines / Q000627:therapeutic use*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy; D014581:Urticaria / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D011759:Pyrrolidines; D002974:Clemastine